Conversion Surgery for Unresectable Pancreatic Cancer with Para-aortic Lymph Node and Liver Metastases and Renal Infiltration—A Case Report—

Key Points

• The aim is to report a successful conversion surgery in a patient with unresectable pancreatic cancer and metastases after chemotherapy.
• Initiated gemcitabine and nab-paclitaxel treatment for unresectable pancreatic cancer with metastases.
• Performed renal function evaluation before surgery to assess feasibility of resection.
• Conducted conversion surgery including resection of the pancreatic tail and affected organs.
• Liver and lymph node metastases disappeared after 3 months of chemotherapy.
• Conversion surgery was performed successfully after confirming sufficient renal function.
• Patient remained recurrence-free two years post-surgery, continuing chemotherapy.